Article Text
Statistics from Altmetric.com
Commentary on: OpenUrlCrossRefPubMedWeb of Science.
Context
The human papillomavirus (HPV) vaccination has been available worldwide since 2006 and over 170 million doses have been distributed. Although the HPV vaccination has demonstrated benefits in preventing precancerous lesions of the cervix, some parents forego vaccination due to safety concerns.1 While not commonly reported, concerns about neurological side effects have been aired in the media. Rigorous postmarketing analyses to assess for unintended sequelae of new medications are warranted and public concerns have prompted several high-quality studies assessing the HPV vaccine safety. Scheller and colleagues evaluated the incidence of multiple sclerosis (MS) and demyelinating diseases that could potentially …
Footnotes
Contributors RBP wrote the commentary and CLC contributed statistical expertise.
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.